• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板中纤溶酶诱导的蛋白酶激活受体4激活的调节。

Regulation of plasmin-induced protease-activated receptor 4 activation in platelets.

作者信息

Mao Yingying, Jin Jianguo, Daniel James L, Kunapuli Satya P

机构信息

Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA.

出版信息

Platelets. 2009 May;20(3):191-8. doi: 10.1080/09537100902803635.

DOI:10.1080/09537100902803635
PMID:19437337
Abstract

Plasmin, a major extracellular protease, activates platelets through PAR4 receptors. Plasmin-induced full aggregation is achieved at lower concentrations (0.1 U/mL) in murine platelets as compared to human platelets (1 U/mL). In COS7 cells expressing the murine PAR4 (mPAR4) receptor, 1 U/mL plasmin caused a higher intracellular calcium mobilization than in cells expressing the human PAR4 (hPAR4) receptor. This difference was reversed when the tethered ligand sequences of mPAR4 and hPAR4 were interchanged through site-directed mutagenesis. We further investigated whether PAR3 expressed in murine platelets serves as a co-receptor for PAR4 activation by plasmin. In COS7 cells, co-expressing mPAR3 and mPAR4, plamsin produced a smaller intracellular calcium mobilization compared to cells expressing mPAR4 alone, suggesting that PAR3 might inhibit plasmin-induced PAR4 stimulation. Consistent with these results, PAR3 null murine platelets also showed a greater plasmin-induced calcium mobilization and aggregation compared to wild-type murine platelets. In conclusion, murine platelets are more sensitive to activation by plasmin than human platelets due to differences in the primary sequence of PAR4. In contrast to thrombin-dependent activation of platelets, wherein PAR3 acts as a co-receptor, mPAR3 inhibits plasmin-induced PAR4 activation.

摘要

纤溶酶是一种主要的细胞外蛋白酶,可通过PAR4受体激活血小板。与人类血小板(1 U/mL)相比,在鼠血小板中,较低浓度(0.1 U/mL)的纤溶酶就能诱导完全聚集。在表达鼠PAR4(mPAR4)受体的COS7细胞中,1 U/mL纤溶酶引起的细胞内钙动员高于表达人类PAR4(hPAR4)受体的细胞。当通过定点诱变互换mPAR4和hPAR4的拴系配体序列时,这种差异发生了逆转。我们进一步研究了鼠血小板中表达的PAR3是否作为纤溶酶激活PAR4的共受体。在共表达mPAR3和mPAR4的COS7细胞中,与单独表达mPAR4的细胞相比,纤溶酶产生的细胞内钙动员较小,这表明PAR3可能抑制纤溶酶诱导的PAR4刺激。与这些结果一致,与野生型鼠血小板相比,PAR3基因敲除的鼠血小板在纤溶酶诱导下也表现出更大的钙动员和聚集。总之,由于PAR4一级序列的差异,鼠血小板对纤溶酶激活比人类血小板更敏感。与凝血酶依赖性激活血小板(其中PAR3作为共受体)相反,mPAR3抑制纤溶酶诱导的PAR4激活。

相似文献

1
Regulation of plasmin-induced protease-activated receptor 4 activation in platelets.血小板中纤溶酶诱导的蛋白酶激活受体4激活的调节。
Platelets. 2009 May;20(3):191-8. doi: 10.1080/09537100902803635.
2
Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.中性粒细胞蛋白酶可使人类PAR3失活,并消除PAR3在小鼠血小板上的共受体功能。
Thromb Haemost. 2001 Mar;85(3):533-8.
3
PAR3 is a cofactor for PAR4 activation by thrombin.PAR3是凝血酶激活PAR4的辅助因子。
Nature. 2000 Apr 6;404(6778):609-13. doi: 10.1038/35007085.
4
Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.纤溶酶对蛋白酶激活受体1(PAR1)凝血酶受体的脱敏作用:动力学、截短位点及其对溶栓治疗的意义。
Biochemistry. 1999 Apr 6;38(14):4572-85. doi: 10.1021/bi9824792.
5
Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.通过分隔的环核苷酸作用对人血小板中蛋白酶激活受体(PAR)1和PAR4信号传导的调节
J Pharmacol Exp Ther. 2007 Aug;322(2):778-88. doi: 10.1124/jpet.107.121830. Epub 2007 May 24.
6
Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca mobilization and ERK phosphorylation in healthy Japanese subjects.健康的日本受试者中,蛋白酶激活受体 4(PAR4)变体通过改变 Ca2+动员和 ERK 磷酸化来影响 PAR4 激活肽诱导的血小板反应性。
Thromb Res. 2018 Feb;162:44-52. doi: 10.1016/j.thromres.2017.12.014. Epub 2017 Dec 24.
7
Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.用纤溶酶对人血小板进行预处理可抑制对凝血酶的反应,但会增强对低浓度聚集剂(包括凝血酶受体激活肽SFLLRN)的反应。
Thromb Haemost. 1997 Apr;77(4):741-7.
8
A dual thrombin receptor system for platelet activation.一种用于血小板激活的双重凝血酶受体系统。
Nature. 1998 Aug 13;394(6694):690-4. doi: 10.1038/29325.
9
Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.YD-3对蛋白酶激活受体4依赖性血小板活化的选择性抑制作用
Thromb Haemost. 2002 Jun;87(6):1026-33.
10
Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.蛋白酶激活受体 4(PAR4)下游的钙动员和蛋白激酶 C 激活受小鼠血小板中 PAR3 的负调控。
PLoS One. 2013;8(2):e55740. doi: 10.1371/journal.pone.0055740. Epub 2013 Feb 6.

引用本文的文献

1
Endothelial protease-activated receptor 4: impotent or important?内皮蛋白酶激活受体4:无作用还是重要?
Front Cardiovasc Med. 2025 Jan 28;12:1541879. doi: 10.3389/fcvm.2025.1541879. eCollection 2025.
2
The effects of tranexamic acid on platelets in patients undergoing cardiac surgery: a systematic review and meta-analysis.氨甲环酸对心脏手术患者血小板的影响:一项系统评价和荟萃分析。
J Thromb Thrombolysis. 2024 Feb;57(2):235-247. doi: 10.1007/s11239-023-02905-8. Epub 2023 Nov 14.
3
LC-MS/MS-based serum proteomics reveals a distinctive signature in a rheumatoid arthritis mouse model after treatment with mesenchymal stem cells.
基于 LC-MS/MS 的血清蛋白质组学揭示了间充质干细胞治疗类风湿关节炎小鼠模型后的独特特征。
PLoS One. 2022 Nov 4;17(11):e0277218. doi: 10.1371/journal.pone.0277218. eCollection 2022.
4
Protease-activated receptor 4: a critical participator in inflammatory response.蛋白酶激活受体 4:炎症反应的关键参与者。
Inflammation. 2015 Apr;38(2):886-95. doi: 10.1007/s10753-014-9999-6.
5
Protease-mediated human smooth muscle cell proliferation by urokinase requires epidermal growth factor receptor transactivation by triple membrane signaling.蛋白酶介导的尿激酶引起的人平滑肌细胞增殖需要通过三联膜信号转导激活表皮生长因子受体。
J Surg Res. 2014 Dec;192(2):254-62. doi: 10.1016/j.jss.2014.06.054. Epub 2014 Jul 2.
6
Biased signaling of protease-activated receptors.蛋白酶激活受体的偏向性信号传导
Front Endocrinol (Lausanne). 2014 May 13;5:67. doi: 10.3389/fendo.2014.00067. eCollection 2014.
7
Complement activation: an emerging player in the pathogenesis of cardiovascular disease.补体激活:心血管疾病发病机制中的一个新角色。
Scientifica (Cairo). 2012;2012:402783. doi: 10.6064/2012/402783. Epub 2012 Dec 16.
8
Trypsin causes platelet activation independently of known protease-activated receptors.Trypsin 可独立于已知的蛋白酶激活受体引起血小板活化。
Thromb Haemost. 2013 Dec;110(6):1241-9. doi: 10.1160/TH13-03-0189. Epub 2013 Sep 12.
9
Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.蛋白酶激活受体 4(PAR4)下游的钙动员和蛋白激酶 C 激活受小鼠血小板中 PAR3 的负调控。
PLoS One. 2013;8(2):e55740. doi: 10.1371/journal.pone.0055740. Epub 2013 Feb 6.
10
Protease-activated receptors in cancer: A systematic review.癌症中的蛋白酶激活受体:一项系统综述。
Oncol Lett. 2011 Jul;2(4):599-608. doi: 10.3892/ol.2011.291. Epub 2011 Apr 8.